SIRT7 and cancer: However, post-mortem gross and microscopic examinations revealed that the incidence of malignant neoplasms was similar between male WT (11 out of 22 mice, 50%) and Sirt7 KO mice (12 out of 21 mice, 57.1%) (Figure 3A).